Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis
Completed · Phase 3 · Has a placebo group
Conditions studied: Relapsing-Remitting Multiple Sclerosis
In brief
To determine if treatment with BG00012 can decrease the number of MS relapses during a certain time period. To determine if, over time, BG00012 treatment can decrease the number of certain types of brain lesions commonly seen in MS patients and slow down the time it takes for the disease to get worse. The purpose of this study is also to determine the safety of BG00012 and how well it is tolerated. Another goal is to see what effect BG00012 may have on tests and evaluations used to assess MS.
Key facts
- Study ID
- NCT00420212
- Run by
- Biogen
- People needed
- 1234
- Starts
- 2007-01-01
- Expected to finish
- 2011-02-01
- Last updated by the study team
- 2015-01-26
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Phoenix, Arizona, United States
- Research Site — San Francisco, California, United States
- Research Site — New Haven, Connecticut, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Vero Beach, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Evanston, Illinois, United States
- Research Site — Palos Heights, Illinois, United States
- Research Site — Fort Wayne, Indiana, United States
- Research Site — Indianapolis, Indiana, United States
- Research Site — Des Moines, Iowa, United States
- Research Site — Wichita, Kansas, United States
- Research Site — Lexington, Kentucky, United States
- Research Site — Brighton, Massachusetts, United States
- Research Site — Hopedale, Massachusetts, United States
- Research Site — Lexington, Massachusetts, United States
- Research Site — Springfield, Massachusetts, United States
- Research Site — Worcester, Massachusetts, United States
- Research Site — Farmington Hills, Michigan, United States
- Research Site — Minneapolis, Minnesota, United States
- Research Site — Columbia, Missouri, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Henderson, Nevada, United States
- Research Site — Las Vegas, Nevada, United States
- Research Site — Gilbert, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.